Alzamend Neuro (ALZN) Net Income (2020 - 2026)
Alzamend Neuro's Net Income was -$3.03 million in fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$2.7 million a year earlier.
Powered by 
Analysis
Alzamend Neuro (ALZN) Net Income (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Alzamend Neuro's Net Income was -$9.1 million through Jul 31, 2026; for FY2026 (ended Apr 30, 2026), it was -$8.77 million.
- In earlier fiscal years, Net Income was -$4.51 million in FY2025, -$9.95 million in FY2024, -$14.88 million in FY2023 and -$12.37 million in FY2022.
- The fiscal Q1 2027 figure marks the lowest quarterly Net Income since fiscal Q1 2024.
- Per Business Quant data, ALZN's Net Income in the three fiscal quarters before Q1 2027 was -$2.87 million (Q4 2026), -$2.2 million (Q3 2026) and -$1 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Alzamend Neuro | 8.35 Mn | 8.35 Mn | - | -3.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -3.03 Mn |
| Apr 30, 2026 | -2.87 Mn |
| Jan 31, 2026 | -2.20 Mn |
| Oct 31, 2025 | -1.00 Mn |
| Jul 31, 2025 | -2.70 Mn |
| Apr 30, 2025 | -1.14 Mn |
| Jan 31, 2025 | -1.04 Mn |
| Oct 31, 2024 | -1.36 Mn |
| Jul 31, 2024 | -974,411.00 |
| Apr 30, 2024 | -851,529.00 |
| Jan 31, 2024 | -2.66 Mn |
| Oct 31, 2023 | -2.91 Mn |
| Jul 31, 2023 | -3.53 Mn |
| Apr 30, 2023 | -3.31 Mn |
| Jan 31, 2023 | -5.43 Mn |
| Oct 31, 2022 | -3.11 Mn |
| Jul 31, 2022 | -3.04 Mn |
| Apr 30, 2022 | -3.87 Mn |
| Jan 31, 2022 | -2.57 Mn |
| Oct 31, 2021 | -3.60 Mn |
API Access
Alzamend Neuro Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();